Japan Generic Drug Market Report 2016 - Industry Trends, Competitive Landscape, Opportunities and Outlook - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook" report to their offering.

The report entitled Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan.

This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of generic drug market in Japan. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Japan.

The landscape of the generic market in Japan, however, has changed noticeably over the last decade. The Japanese government has identified growth of the country's generic drug market as imperative to Japan's long-term economic health. The Japanese government, recognizing the country's increasing aging population as well as rising costs of branded drugs has begun instituting healthcare policy changes to cut their expenditures on medical costs.

Driven by these initiatives, the penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2017. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.

Key Topics Covered:

1 Research Methodology and Market Definitions

2 Report Summary

3 Japan Generic Drug Market - Introduction

4 Why is the Japanese Generic Drug Market so Lucrative

5 Global Generic Drug Market

6 Japan Generic Drug Market

7 Japan Generic Drug Market- Competitive Landscape

8 Japan Generic Drug Market - Value Chain Analysis

9 Regulations in Japan Generics Industry

10 Japan Generic Drug Market: Key Success Factors

11 Japan Generic Drug Market: Road Blocks

12 Requirements for Setting up a Generic Drug Manufacturing Plant

13 Japan Generic Drug Market - Key Company Profiles

13.1 Teva Pharmaceutical Ltd.

13.2 Sawai Pharmaceutical Co., Ltd.

13.3 Nichi-Iko Pharmaceutical Co., Ltd.

13.4 Pfizer Japan Inc.

13.5 Meiji Seika Pharma

13.6 Towa Pharmaceutical

13.7 Nipro Pharma Corporation

13.8 Fuji Pharma Co., Ltd.

13.9 Daiichi Sankyo Espha Co., Ltd.

13.10 Nihon Generic Co. Ltd.

For more information visit http://www.researchandmarkets.com/research/lbpkpj/japan_generic

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs